Biotech Archives - Spark Newswire

2 minute read

Revolutionizing Sustainable Cannabis Vaping, Greentank Technologies Closes $16.5M Series B

March 31, 4:57 PM

Greentank Technologies, a business-to-business technology company specializing in the design, development and manufacture of precision-made vaporization hardware and atomization technology, secured $16.5 million in Series B funding to accelerate growth in sustainable cannabis vaping tech.

OGI

1 minute read

NRx Pharma Raises Doubt To Continue As Going Concern

By Vandana Singh

March 31, 12:16 PM

NRx Pharmaceuticals Inc (NASDAQ:NRXP) shares are down Friday as it evaluated whether there are any conditions or events that could raise…

NRXP

1 minute read

Cytokinetics Plans To Discontinue Late-Stage ALS Trial Due To Futility

By Vandana Singh

March 31, 11:44 AM

Cytokinetics Incorporated (NASDAQ: CYTK) announced that the Data Monitoring Committee (DMC) for COURAGE-ALS recently convened to conduct the second planned interim analysis of this Phase 3 clinical trial.

CYTK

4 minute read

Top 5 Best And Worst U.S. Industry ETFs In Q1 2023: AI and Bank Turmoil Shaped Stock Returns

By Piero Cingari

March 31, 11:34 AM

The first quarter of 2023 was positive for the U.S. stock market as a whole, with the S&P 500 index faithfully tracked by the SPDR S&P 500 ETF Trust (ARCA: SPY), rising by 6%.

ACDC

1 minute read

Texas Judge Obstructs Affordable Act Coverage Mandate For Some Cancer Screenings, Prophylaxis

By Vandana Singh

March 31, 10:47 AM

A Texas federal judge reportedly blocked Obamacare's mandate that health insurance plans cover preventive care, including screenings for certain cancers and pre-exposure prophylaxis against HIV (PrEP), at no cost to patients. The ruling does not apply to preventive services, such as breast cancer screening, recommended before Obamacare was enacted in 2010.

GILD

1 minute read

Aptinyx Evaluates Strategic Alternatives For Its Future After Failed Trials, 60% Layoffs

By Vandana Singh

March 31, 10:30 AM

In March, Aptinyx Inc (NASDAQ:APTX) completed an analysis of the data from the first 100 patients enrolled in its Phase 2b clinical…

APTX

1 minute read

Stage Set For Generics As Biden Admin Asks Supreme Court To Hear Skinny Labels Case Between GSK, Teva

By Vandana Singh

March 31, 10:10 AM

The Biden Administration told the U.S. Supreme Court that it should agree to hear a patent appeal over…

GSK

3 minute read

Prothena Presents New Preclinical Data Supporting Best-In-Class Profile Of PRX012, A Next-Generation Anti-Amyloid Beta Antibody, At AD/PD 2023

By Happy Mohamed

March 31, 9:20 AM

Data from oral presentation adds to growing body of evidence supporting the profile of PRX012, which is designed to target all aggregated forms of amyloid beta with high binding potency Demonstrated 20-fold higher

PRTA

4 minute read

Nexcella, An Immix Biopharma Subsidiary, Announces 2023 Haematologica Editorial Highlighting NXC-201 Efficacy In The Context Of U.S. Food And Drug Administration Approved BCMA CAR T Cells

By Happy Mohamed

March 31, 8:10 AM

Nexcella, Inc., a subsidiary of Immix Biopharma, Inc. (NASDAQ:IMMX) ("ImmixBio", "Company", "We" or "Us") today announced that an editorial written by Maria Sjöstrand and

IMMX

1 minute read

Eisai-Biogen Highlights Additional Data From Recently Approved Alzheimer’s Drug

By Vandana Singh

March 31, 7:57 AM

Eisai Co Ltd (OTC:ESALY) and Biogen Inc (NASDAQ:BIIB) announced that three additional detailed analyses from the Phase IIb clinical study (Study 201) of…

BIIB